摘要:
Disclosed is a high-strength bolt having a tensile strength of 1,200 N/mm2 or more and superior in delayed fracture resistance and relaxation resistance, prepared by wire-drawing a bolt steel containing the following elements: C: 0.5 to 1.0% (mass %, the same shall apply hereinafter), Si: 0.55 to 3%, Mn: 0.2 to 2%, P: 0.03% or less (but not 0%), S: 0.03% or less (but not 0%), and Al: 0.3% or less (but not 0%), and containing proeutectoid ferrite, proeutectoid cementite, bainite and martensite at a total areal rate of less than 20% and pearlite in balance; cold-heading the wire into a bolt shape; and then bluing the bolt in a temperature range of 100 to 500° C.
摘要翻译:公开了通过拉拔含有以下元素的螺栓钢制备的拉伸强度为1200N / mm 2以上的耐久性和耐松弛性优异的高强度螺栓:C :0.5〜1.0%(质量%,以下相同),Si:0.55〜3%,Mn:0.2〜2%,P:0.03%以下(但不为0%),S:0.03%以下 但不是0%),Al:0.3%以下(但不是0%),并且总共面积率小于20%的前共析铁素体,共析铁素体,贝氏体和马氏体,平衡的珠光体; 将钢丝冷拔成螺栓形状; 然后在100〜500℃的温度范围内使螺栓上蓝。
摘要:
A member produced by powder forging which retains machinability and improved fatigue strength without having an increased hardness and can retain self conformability after fracture splitting; a powder mixture for powder forging; a process for producing a member by powder forging; and a fracture splitting connecting rod obtained from the member produced by powder forging. The member produced by powder forging is one obtained by preforming a powder mixture, subsequently sintering the preform, and forging the resultant sintered preform at a high temperature. The free-copper proportion in the sintered preform at the time when the forging is started is 10% or lower, and the member obtained through the forging has a composition containing, in terms of mass %, 0.2-0.4% C, 3-5% Cu, and up to 0.4% Mn (excluding 0), the remainder being iron and incidental impurities, and has a ferrite content of 40-90%.
摘要:
A non-heat treated connecting rod which comprises, by mass %, C: 0.25-0.35%, Si: 0.50-0.70%, Mn: 0.60-0.90%, P: 0.040-0.070%, S: 0.040-0.130%, Cr: 0.10-0.20%, V: 0.15-0.20%, Ti: 0.15-0.20% and N: 0.002-0.020%, and the balance Fe and impurities, with chemical compositions being less than 0.80 in the value of C+(Si/10)+(Mn/5)+(5Cr/22)+1.65 V−(5S/7) using the symbol of the element as its content, the microstructure of the Big end of the said connecting rod being ferrite-pearlite, all-region hardness of the said big end being 255 to 320 in Vickers hardness, the ferrite-region hardness in the said ferrite-pearlite of the Big end being 250 or more in Vickers hardness and the ratio of the said ferrite-region hardness to the said all-region hardness of the said Big end being 0.80 or more, is excellent in machinability, fracture splitting ability, and fatigue resistance, although no Pb at all is added. Therefore, this non-heat treated connecting rod can be utilized as a low cost type connecting rod in automobile engines or the like.
摘要:
A non-heat treated connecting rod which comprises, by mass %, C: 0.25-0.35%, Si: 0.50-0.70%, Mn: 0.60-0.90%, P: 0.040-0.070%, S: 0.040-0.130%, Cr: 0.10-0.20%, V: 0.15-0.20%, Ti: 0.15-0.20% and N: 0.002-0.020%, and the balance Fe and impurities, with chemical compositions being less than 0.80 in the value of C+(Si/10)+(Mn/5)+(5Cr/22)+1.65 V−(5S/7) using the symbol of the element as its content, the microstructure of the Big end of the said connecting rod being ferrite-pearlite, all-region hardness of the said big end being 255 to 320 in Vickers hardness, the ferrite-region hardness in the said ferrite-pearlite of the Big end being 250 or more in Vickers hardness and the ratio of the said ferrite-region hardness to the said all-region hardness of the said Big end being 0.80 or more, is excellent in machinability, fracture splitting ability, and fatigue resistance, although no Pb at all is added. Therefore, this non-heat treated connecting rod can be utilized as a low cost type connecting rod in automobile engines or the like.
摘要:
Disclosed are methods of enhancing the chemotherapeutic treatment of tumor cells, reducing resistance of a cancer cell to a chemotherapeutic agent, a method of inhibiting ABCG2, Pgp, or MRP1 in a mammal afflicted with cancer, and a method of increasing the bioavailability of an ABCG2 substrate drug in a mammal. The methods comprise administering effective amounts of certain compounds to the mammal, for example, a compound of the formula (I): Formula (I), wherein R1, R2, R3, X1, X2, X3, a, and b are as described herein. Uses of these compounds in the preparation of a medicament are also disclosed. Also disclosed are compounds of formula (II), pharmaceutical compositions comprising such compounds and uses thereof.
摘要:
A steel used in a belt-type CVT that is superior in wear resistance and toughness, and a steel for cold punching, that provides the same. The steel satisfies the following: 10.8 [C]+5.6 [Si]+2.7 [Mn]+0.3 [Cr]+7.8 [Mo]+1.4 [V]≦13. The steel contains C within the range of 0.50 to 0.70%, Si within the range of 0.03 to 0.60%, Mn within the range of 0.50 to 1.00%, Cr within the range of 0.20 to 1.00%, Ti within the range of 0.01 to 0.10%, and B within the range of 0.0005 to 0.0050% by mass as required additional elements, P within the range of 0.025% or less and S within the range of 0.015% or less by mass as optional additional elements, and the remainder as Fe and unavoidable impurities.
摘要:
Disclosed are methods of enhancing the chemotherapeutic treatment of tumor cells, reducing resistance of a cancer cell to a chemotherapeutic agent, a method of inhibiting ABCG2, Pgp, or MRP1 in a mammal afflicted with cancer, and a method of increasing the bioavailability of an ABCG2 substrate drug in a mammal. The methods comprise administering effective amounts of certain compounds to the mammal, for example, a compound of the formula (I): Formula (I), wherein R1, R2, R3, X1, X2, X3, a, and b are as described herein. Uses of these compounds in the preparation of a medicament are also disclosed. Also disclosed are compounds of formula (II), pharmaceutical compositions comprising such compounds and uses thereof.